PL2146719T3 - Sposób wytwarzania galantaminy - Google Patents
Sposób wytwarzania galantaminyInfo
- Publication number
- PL2146719T3 PL2146719T3 PL08727257T PL08727257T PL2146719T3 PL 2146719 T3 PL2146719 T3 PL 2146719T3 PL 08727257 T PL08727257 T PL 08727257T PL 08727257 T PL08727257 T PL 08727257T PL 2146719 T3 PL2146719 T3 PL 2146719T3
- Authority
- PL
- Poland
- Prior art keywords
- galantamine
- making
- making galantamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92319107P | 2007-04-12 | 2007-04-12 | |
EP08727257.1A EP2146719B1 (en) | 2007-04-12 | 2008-04-02 | Process for making galantamine |
PCT/US2008/004303 WO2008127560A1 (en) | 2007-04-12 | 2008-04-02 | Process for making galantamine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2146719T3 true PL2146719T3 (pl) | 2013-12-31 |
Family
ID=39854337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08727257T PL2146719T3 (pl) | 2007-04-12 | 2008-04-02 | Sposób wytwarzania galantaminy |
Country Status (14)
Country | Link |
---|---|
US (1) | US7985879B2 (es) |
EP (1) | EP2146719B1 (es) |
JP (1) | JP5441883B2 (es) |
KR (1) | KR101172044B1 (es) |
CN (1) | CN101674835B (es) |
AR (1) | AR066054A1 (es) |
AU (1) | AU2008239730B2 (es) |
CA (1) | CA2683098C (es) |
ES (1) | ES2432405T3 (es) |
NZ (1) | NZ580271A (es) |
PL (1) | PL2146719T3 (es) |
SI (1) | SI2146719T1 (es) |
TW (1) | TWI343909B (es) |
WO (1) | WO2008127560A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102532149B (zh) * | 2011-12-14 | 2015-05-13 | 南开大学 | 加兰他敏和力可拉敏的不对称合成方法 |
CN113292420A (zh) * | 2021-05-27 | 2021-08-24 | 神隆医药(常熟)有限公司 | 加兰他敏中间体原料2-溴-5-羟基-4-甲氧基苯甲酸回收方法 |
CN113683491A (zh) * | 2021-09-01 | 2021-11-23 | 王传良 | 一种4-(2-溴乙基)苯酚的制备方法 |
CN113620821A (zh) * | 2021-09-01 | 2021-11-09 | 广汉市派瑞林科技有限责任公司 | 一种大麦芽碱盐酸盐的制备方法 |
CN113683522A (zh) * | 2021-09-01 | 2021-11-23 | 广汉市派瑞林科技有限责任公司 | 一种n-甲基酪胺盐酸盐的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8514679D0 (en) * | 1985-06-11 | 1985-07-10 | Beecham Group Plc | Compounds |
US5831002A (en) * | 1992-05-20 | 1998-11-03 | Basf Aktiengesellschaft | Antitumor peptides |
EP0787115B1 (de) | 1994-10-21 | 2000-01-05 | Sanochemia Pharmazeutika AG | VERFAHREN ZUM HERSTELLEN VON DERIVATEN DES 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINS |
GB9506843D0 (en) | 1995-04-03 | 1995-05-24 | Chiroscience Ltd | Oxidative process and products thereof |
CA2540248C (en) * | 2003-09-26 | 2010-12-07 | Scinopharm Taiwan, Ltd. | Resolution of a narwedine amide derivative |
US20060009640A1 (en) * | 2004-07-08 | 2006-01-12 | Bolugoddu Vijaya B | Preparation of (-)-galantamine hydrobromide |
JP2007039466A (ja) * | 2004-11-29 | 2007-02-15 | Japan Tobacco Inc | 窒素含有縮合環化合物及びその用途 |
WO2006072818A2 (en) * | 2005-01-04 | 2006-07-13 | Emcure Pharmaceuticals Limited | Process for preparation of galanthamine |
ATE459627T1 (de) * | 2005-05-03 | 2010-03-15 | Medichem Sa | Synthesen und herstellungen von narwedin und verwandten neuen verbindungen |
-
2008
- 2008-04-02 NZ NZ580271A patent/NZ580271A/en not_active IP Right Cessation
- 2008-04-02 EP EP08727257.1A patent/EP2146719B1/en not_active Not-in-force
- 2008-04-02 CN CN2008800117624A patent/CN101674835B/zh not_active Expired - Fee Related
- 2008-04-02 CA CA2683098A patent/CA2683098C/en not_active Expired - Fee Related
- 2008-04-02 ES ES08727257T patent/ES2432405T3/es active Active
- 2008-04-02 SI SI200831021T patent/SI2146719T1/sl unknown
- 2008-04-02 AU AU2008239730A patent/AU2008239730B2/en not_active Ceased
- 2008-04-02 KR KR1020097021927A patent/KR101172044B1/ko not_active IP Right Cessation
- 2008-04-02 PL PL08727257T patent/PL2146719T3/pl unknown
- 2008-04-02 JP JP2010503016A patent/JP5441883B2/ja not_active Expired - Fee Related
- 2008-04-02 US US12/080,380 patent/US7985879B2/en not_active Expired - Fee Related
- 2008-04-02 WO PCT/US2008/004303 patent/WO2008127560A1/en active Application Filing
- 2008-04-10 TW TW097113083A patent/TWI343909B/zh not_active IP Right Cessation
- 2008-04-11 AR ARP080101531A patent/AR066054A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2146719A4 (en) | 2012-07-04 |
TW200902483A (en) | 2009-01-16 |
US20080255347A1 (en) | 2008-10-16 |
KR101172044B1 (ko) | 2012-08-08 |
ES2432405T3 (es) | 2013-12-03 |
JP2010523658A (ja) | 2010-07-15 |
CN101674835B (zh) | 2013-12-11 |
NZ580271A (en) | 2011-03-31 |
JP5441883B2 (ja) | 2014-03-12 |
CA2683098C (en) | 2014-03-18 |
AR066054A1 (es) | 2009-07-22 |
CA2683098A1 (en) | 2008-10-23 |
TWI343909B (en) | 2011-06-21 |
US7985879B2 (en) | 2011-07-26 |
KR20100015748A (ko) | 2010-02-12 |
AU2008239730B2 (en) | 2011-10-06 |
AU2008239730A1 (en) | 2008-10-23 |
SI2146719T1 (sl) | 2013-10-30 |
EP2146719B1 (en) | 2013-08-14 |
CN101674835A (zh) | 2010-03-17 |
EP2146719A1 (en) | 2010-01-27 |
WO2008127560A1 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0715101D0 (en) | Process | |
EP2173736A4 (en) | PROCESS FOR PREPARING VORICONAZOLE | |
EP2123631A4 (en) | PROCESS FOR THE PREPARATION OF ALKOXYPROPIONAMIDE | |
GB0711624D0 (en) | Process | |
GB0700074D0 (en) | process | |
GB0716126D0 (en) | Process | |
EP2152631A4 (en) | NICKEL LATERITE PROCEDURE | |
GB0711680D0 (en) | Process | |
GB0714602D0 (en) | Process | |
EP2328900A4 (en) | PROCESS FOR PREPARING MORPHINAN-6 alpha-OLS | |
EP2221306A4 (en) | PROCESS FOR PREPARING 2-AZAADAMANTANE | |
ZA201009104B (en) | Process for making substituted 2-amino-thiazolones | |
GB0714390D0 (en) | Process | |
EP2146719A4 (en) | PROCESS FOR PREPARING GALANTAMINE | |
GB0700878D0 (en) | Process | |
GB201003018D0 (en) | Process | |
GB0724716D0 (en) | Process | |
HU0700461D0 (en) | Process for producing 9alpha-hydroxy-steroids | |
PL2152091T5 (pl) | Sposób | |
EP2154125A4 (en) | PROCESS FOR PRODUCTION OF ARYLHYDROXYLAMINE | |
HU0700411D0 (en) | Process for producing quetiapin | |
GB0719251D0 (en) | Process | |
IL201455A0 (en) | Process for making topotecan | |
ZA201001017B (en) | Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline | |
GB0701966D0 (en) | Process |